Doctors say new gene-based treatments could offer long-term relief — and possible cures — for people living with sickle cell disease. Sickle cell disease has long shortened lives in the United States, ...

Renizgamglogene autogedtemcel (reni-cel) is an investigational clustered regularly interspaced short palindromic repeats (CRISPR)–Cas12a gene-edited autologous hematopoietic stem-cell therapy. The ...

Please provide your email address to receive an email when new articles are posted on . Two studies highlight the potential of gene editing for sickle cell disease treatment. Despite increasing ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

The U.S. Patent and Trademark Office has accepted a groundbreaking patent from Dei BioPharma Ltd., marking a significant milestone in the treatment of sickle cell disease. Dei BioPharma, a Ugandan ...

Add Yahoo as a preferred source to see more of our stories on Google. Sickle cell disease reshapes healthy round blood cells into a sickled C-shape. As these sticky cells clump up, they can block ...

Hydroxyurea (also called hydroxycarbamide) is a small molecule antimetabolite that inhibits ribonucleotide reductase, an enzyme that catalyzes the conversion of ribonucleotides to deoxyribonucleotides ...

Medical history has been made in Louisiana. On Tuesday, the first person in the state to receive gene therapy for sickle cell disease left the hospital after a six-week-long stay. The hope is that ...

Sickle cell disease reshapes healthy round blood cells into a sickled C-shape. As these sticky cells clump up, they can block blood from getting to your tissues, so it cant deliver needed oxygen. When ...